Centene Corporation (CNC) EV/Sales Ratio: 0.14x
Is Centene Corporation’s EV/Sales ratio high or low?
Centene Corporation's EV/Sales ratio of 0.14x is 51% below its 5-year average of 0.29x, near the low end of its 5-year range (0.08x–0.49x).
As of Thursday, June 11, 2026. 24.84% above its 12-month average of 0.11x.
CNC EV/Sales Ratio Chart
CNC Average EV/Sales Ratio Chart
CNC Current vs Average EV/Sales Ratio Chart
CNC EV/Sales Ratio Metrics
EV/SALES RATIO
0.14x
EV/SALES RATIO AVG TTM
0.11x
EV/SALES RATIO AVG 3Y
0.20x
EV/SALES RATIO AVG 5Y
0.29x
EV/SALES RATIO AVG 10Y
0.34x
EV/SALES RATIO AVG 15Y
0.34x
EV/SALES RATIO AVG 20Y
0.34x
CURRENT VS TTM AVG
+24.84%
CURRENT VS 3Y AVG
-31.26%
CURRENT VS 5Y AVG
-50.99%
CURRENT VS 10Y AVG
-59.10%
CURRENT VS 15Y AVG
-58.78%
CURRENT VS 20Y AVG
-58.33%
CNC Competitors' EV/Sales Ratio
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Centene Corporation (CNC) | $32.26B | 0.14x | 0.11x | 0.20x | 0.29x |
| Medline Inc. (MDLN) | $30.90B | 1.39x | 1.60x | 1.60x | 1.60x |
| Zoetis Inc. (ZTS) | $34.27B | 4.40x | 6.71x | 8.77x | 9.90x |
| IQVIA Holdings Inc. (IQV) | $30.08B | 1.85x | 2.83x | 3.22x | 3.53x |
| Biogen Inc. (BIIB) | $28.94B | 3.26x | 2.79x | 3.30x | 3.58x |
| DexCom, Inc. (DXCM) | $28.92B | 6.18x | 6.63x | 10.22x | 13.87x |
| Agilent Technologies, Inc. (A) | $37.17B | 5.38x | 5.56x | 5.75x | 6.21x |
| Veeva Systems Inc. (VEEV) | $26.73B | 7.65x | 12.50x | 13.33x | 15.70x |
| Waters Corporation (WAT) | $23.60B | 9.23x | 7.04x | 7.13x | 7.32x |
| Mettler-Toledo International Inc. (MTD) | $22.82B | 6.13x | 7.35x | 7.51x | 8.18x |
Understanding EV/Sales
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
- It works for unprofitable companies where P/E doesn't apply
- Revenue is harder to manipulate than earnings
- It supports comparisons across companies at different profitability stages
- It is frequently used for software and other revenue-growth-focused companies
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
Centene Corporation EV/Sales Ratio Formula & Definition
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Centene Corporation EV/Sales Ratio FAQ
- What is the EV/Sales ratio for Centene Corporation (CNC)?
- The EV/Sales ratio for CNC stock is 0.14x.
- Is Centene Corporation's EV/Sales ratio high or low?
- Centene Corporation's EV/Sales ratio of 0.14x is 51% below its 5-year average of 0.29x, near the low end of its 5-year range (0.08x–0.49x).
- What is the TTM average EV/Sales ratio for Centene Corporation (CNC)?
- The TTM average EV/Sales ratio for CNC stock is 0.11x.
- What is the 3Y average EV/Sales ratio for Centene Corporation (CNC)?
- The 3Y average EV/Sales ratio for CNC stock is 0.20x.
- What is the 5Y average EV/Sales ratio for Centene Corporation (CNC)?
- The 5Y average EV/Sales ratio for CNC stock is 0.29x.
- What is the 10Y average EV/Sales ratio for Centene Corporation (CNC)?
- The 10Y average EV/Sales ratio for CNC stock is 0.34x.
- What is the 15Y average EV/Sales ratio for Centene Corporation (CNC)?
- The 15Y average EV/Sales ratio for CNC stock is 0.34x.
- What is the 20Y average EV/Sales ratio for Centene Corporation (CNC)?
- The 20Y average EV/Sales ratio for CNC stock is 0.34x.
Centene Corporation EV/Sales Ratio History
| DATE | EV/SALES RATIO |
|---|---|
| 2026-06-10 | 0.14x |
| 2026-06-09 | 0.14x |
| 2026-06-08 | 0.14x |
| 2026-06-05 | 0.13x |
| 2026-06-04 | 0.13x |
| 2026-06-03 | 0.12x |
| 2026-06-02 | 0.13x |
| 2026-06-01 | 0.13x |
| 2026-05-29 | 0.12x |
| 2026-05-28 | 0.12x |
| 2026-05-27 | 0.12x |
| 2026-05-26 | 0.12x |
| 2026-05-22 | 0.12x |
| 2026-05-21 | 0.12x |
| 2026-05-20 | 0.12x |
| 2026-05-19 | 0.12x |
| 2026-05-18 | 0.12x |
| 2026-05-15 | 0.12x |
| 2026-05-14 | 0.12x |
| 2026-05-13 | 0.12x |
| 2026-05-12 | 0.12x |
| 2026-05-11 | 0.12x |
| 2026-05-08 | 0.12x |
| 2026-05-07 | 0.11x |
| 2026-05-06 | 0.11x |
| 2026-05-05 | 0.11x |
| 2026-05-04 | 0.11x |
| 2026-05-01 | 0.11x |
| 2026-04-30 | 0.11x |
| 2026-04-29 | 0.11x |
| 2026-04-28 | 0.10x |
| 2026-04-27 | 0.08x |
| 2026-04-24 | 0.11x |
| 2026-04-23 | 0.11x |
| 2026-04-22 | 0.10x |
| 2026-04-21 | 0.10x |
| 2026-04-20 | 0.10x |
| 2026-04-17 | 0.10x |
| 2026-04-16 | 0.10x |
| 2026-04-15 | 0.10x |
| 2026-04-14 | 0.10x |
| 2026-04-13 | 0.10x |
| 2026-04-10 | 0.10x |
| 2026-04-09 | 0.10x |
| 2026-04-08 | 0.10x |
| 2026-04-07 | 0.10x |
| 2026-04-06 | 0.09x |
| 2026-04-02 | 0.09x |
| 2026-04-01 | 0.09x |
| 2026-03-31 | 0.09x |
| 2026-03-30 | 0.08x |
| 2026-03-27 | 0.09x |
| 2026-03-26 | 0.09x |
| 2026-03-25 | 0.09x |
| 2026-03-24 | 0.09x |
| 2026-03-23 | 0.09x |
| 2026-03-20 | 0.09x |
| 2026-03-19 | 0.09x |
| 2026-03-18 | 0.10x |
| 2026-03-17 | 0.09x |
| 2026-03-16 | 0.09x |
| 2026-03-13 | 0.09x |
| 2026-03-12 | 0.09x |
| 2026-03-11 | 0.09x |
| 2026-03-10 | 0.10x |
| 2026-03-09 | 0.11x |
| 2026-03-06 | 0.11x |
| 2026-03-05 | 0.11x |
| 2026-03-04 | 0.12x |
| 2026-03-03 | 0.12x |
| 2026-03-02 | 0.12x |
| 2026-02-27 | 0.12x |
| 2026-02-26 | 0.11x |
| 2026-02-25 | 0.11x |
| 2026-02-24 | 0.11x |
| 2026-02-23 | 0.11x |
| 2026-02-20 | 0.11x |
| 2026-02-19 | 0.11x |
| 2026-02-18 | 0.11x |
| 2026-02-17 | 0.11x |
| 2026-02-13 | 0.11x |
| 2026-02-12 | 0.11x |
| 2026-02-11 | 0.11x |
| 2026-02-10 | 0.11x |
| 2026-02-09 | 0.10x |
| 2026-02-06 | 0.10x |
| 2026-02-05 | 0.11x |
| 2026-02-04 | 0.11x |
| 2026-02-03 | 0.12x |
| 2026-02-02 | 0.12x |
| 2026-01-30 | 0.12x |
| 2026-01-29 | 0.12x |
| 2026-01-28 | 0.11x |
| 2026-01-27 | 0.11x |
| 2026-01-26 | 0.13x |
| 2026-01-23 | 0.12x |
| 2026-01-22 | 0.12x |
| 2026-01-21 | 0.12x |
| 2026-01-20 | 0.12x |
| 2026-01-16 | 0.12x |
| 2026-01-15 | 0.13x |
| 2026-01-14 | 0.12x |
| 2026-01-13 | 0.12x |
| 2026-01-12 | 0.13x |
| 2026-01-09 | 0.13x |
| 2026-01-08 | 0.13x |
| 2026-01-07 | 0.12x |
| 2026-01-06 | 0.12x |
| 2026-01-05 | 0.12x |
| 2026-01-02 | 0.11x |
| 2025-12-31 | 0.11x |
| 2025-12-30 | 0.11x |
| 2025-12-29 | 0.11x |
| 2025-12-26 | 0.11x |
| 2025-12-24 | 0.11x |
| 2025-12-23 | 0.11x |
| 2025-12-22 | 0.11x |
| 2025-12-19 | 0.11x |
| 2025-12-18 | 0.11x |
| 2025-12-17 | 0.11x |
| 2025-12-16 | 0.11x |
| 2025-12-15 | 0.11x |
| 2025-12-12 | 0.11x |
| 2025-12-11 | 0.11x |
| 2025-12-10 | 0.11x |
| 2025-12-09 | 0.10x |
| 2025-12-08 | 0.10x |
| 2025-12-05 | 0.10x |
| 2025-12-04 | 0.11x |
| 2025-12-03 | 0.11x |
| 2025-12-02 | 0.11x |
| 2025-12-01 | 0.10x |
| 2025-11-28 | 0.11x |
| 2025-11-26 | 0.11x |
| 2025-11-25 | 0.11x |
| 2025-11-24 | 0.10x |
| 2025-11-21 | 0.10x |
| 2025-11-20 | 0.09x |
| 2025-11-19 | 0.10x |
| 2025-11-18 | 0.10x |
| 2025-11-17 | 0.10x |
| 2025-11-14 | 0.10x |
| 2025-11-13 | 0.10x |
| 2025-11-12 | 0.10x |
| 2025-11-11 | 0.10x |
| 2025-11-10 | 0.09x |
| 2025-11-07 | 0.10x |
| 2025-11-06 | 0.10x |
| 2025-11-05 | 0.10x |
| 2025-11-04 | 0.10x |
| 2025-11-03 | 0.09x |
| 2025-10-31 | 0.10x |
| 2025-10-30 | 0.10x |
| 2025-10-29 | 0.10x |
| 2025-10-28 | 0.09x |
| 2025-10-27 | 0.11x |
| 2025-10-24 | 0.11x |
| 2025-10-23 | 0.11x |
| 2025-10-22 | 0.12x |
| 2025-10-21 | 0.12x |
| 2025-10-20 | 0.12x |
| 2025-10-17 | 0.11x |
| 2025-10-16 | 0.12x |
| 2025-10-15 | 0.12x |
| 2025-10-14 | 0.12x |
| 2025-10-13 | 0.12x |
| 2025-10-10 | 0.12x |
| 2025-10-09 | 0.12x |
| 2025-10-08 | 0.12x |
| 2025-10-07 | 0.12x |
| 2025-10-06 | 0.12x |
| 2025-10-03 | 0.12x |
| 2025-10-02 | 0.12x |
| 2025-10-01 | 0.12x |
| 2025-09-30 | 0.12x |
| 2025-09-29 | 0.11x |
| 2025-09-26 | 0.11x |
| 2025-09-25 | 0.11x |
| 2025-09-24 | 0.11x |
| 2025-09-23 | 0.11x |
| 2025-09-22 | 0.11x |
| 2025-09-19 | 0.11x |
| 2025-09-18 | 0.11x |
| 2025-09-17 | 0.11x |
| 2025-09-16 | 0.11x |
| 2025-09-15 | 0.11x |
| 2025-09-12 | 0.11x |
| 2025-09-11 | 0.11x |
| 2025-09-10 | 0.10x |
| 2025-09-09 | 0.10x |
| 2025-09-08 | 0.10x |
| 2025-09-05 | 0.10x |
| 2025-09-04 | 0.10x |
| 2025-09-03 | 0.10x |
| 2025-09-02 | 0.10x |
| 2025-08-29 | 0.10x |
| 2025-08-28 | 0.10x |
| 2025-08-27 | 0.10x |
| 2025-08-26 | 0.10x |
| 2025-08-25 | 0.10x |
| 2025-08-22 | 0.10x |
| 2025-08-21 | 0.10x |
| 2025-08-20 | 0.10x |
| 2025-08-19 | 0.10x |
| 2025-08-18 | 0.10x |
| 2025-08-15 | 0.10x |
| 2025-08-14 | 0.09x |
| 2025-08-13 | 0.09x |
| 2025-08-12 | 0.09x |
| 2025-08-11 | 0.09x |
| 2025-08-08 | 0.09x |
| 2025-08-07 | 0.09x |
| 2025-08-06 | 0.09x |
| 2025-08-05 | 0.09x |
| 2025-08-04 | 0.09x |
| 2025-08-01 | 0.09x |
| 2025-07-31 | 0.09x |
| 2025-07-30 | 0.09x |
| 2025-07-29 | 0.09x |
| 2025-07-28 | 0.09x |
| 2025-07-25 | 0.10x |
| 2025-07-24 | 0.09x |
| 2025-07-23 | 0.11x |
| 2025-07-22 | 0.10x |
| 2025-07-21 | 0.10x |
| 2025-07-18 | 0.10x |
| 2025-07-17 | 0.11x |
| 2025-07-16 | 0.11x |
| 2025-07-15 | 0.11x |
| 2025-07-14 | 0.11x |
| 2025-07-11 | 0.11x |
| 2025-07-10 | 0.12x |
| 2025-07-09 | 0.12x |
| 2025-07-08 | 0.12x |
| 2025-07-07 | 0.12x |
| 2025-07-03 | 0.12x |
| 2025-07-02 | 0.12x |
| 2025-07-01 | 0.19x |
| 2025-06-30 | 0.18x |
| 2025-06-27 | 0.18x |
| 2025-06-26 | 0.18x |
| 2025-06-25 | 0.18x |
| 2025-06-24 | 0.18x |
| 2025-06-23 | 0.18x |
| 2025-06-20 | 0.18x |
| 2025-06-18 | 0.18x |
| 2025-06-17 | 0.18x |
| 2025-06-16 | 0.18x |
| 2025-06-13 | 0.18x |
| 2025-06-12 | 0.18x |
| 2025-06-11 | 0.18x |
| 2025-06-10 | 0.18x |
| 2025-06-09 | 0.18x |
| 2025-06-06 | 0.18x |
| 2025-06-05 | 0.18x |
| 2025-06-04 | 0.18x |
| 2025-06-03 | 0.18x |
| 2025-06-02 | 0.18x |
| 2025-05-30 | 0.19x |
| 2025-05-29 | 0.19x |
Showing the most recent 260 of 5,031 data points. The chart above shows the full history.
Related Metrics
About Centene Corporation
Centene Corporation functions as a diverse, multinational healthcare organization, primarily dedicated to delivering a comprehensive range of programs and services to underinsured and uninsured individuals throughout the United States. Its Managed Care division provides extensive health plan coverage for people enrolled in various government-sponsored initiatives. These initiatives include Medicaid, the State Children's Health Insurance Program (SCHIP), long-term services and support, foster care, and specialized Medicare-Medicaid plans that cater to individuals dually eligible for both programs, as well as aged, blind, or disabled populations. The broad spectrum of benefits within these health plans encompasses primary and specialty physician care, inpatient and outpatient hospital services, emergency and urgent care, prenatal support, laboratory and X-ray diagnostics, and home-based primary care. Complementary services feature transportation assistance, vision and dental care, telehealth access, immunizations, specialty pharmacy, therapy, social work, nurse advisory support, and care coordination. Additionally, members are covered for prescriptions, limited over-the-counter medications, medical equipment, and essential behavioral health and substance abuse services. This segment also extends its offerings to commercial healthcare products for individuals and employer groups of various sizes. Centene's Specialty Services segment delivers a distinct set of solutions, including pharmacy benefits management (PBM), 24/7 nurse advice lines and after-hours support, vision and dental services, and staffing provisions for correctional systems and other government agencies. This division also serves beneficiaries eligible for the Military Health System. Its clientele for these specialized services spans state programs, correctional institutions, healthcare organizations, employer groups, and other commercial entities. The company delivers its healthcare services through an expansive network comprising primary and specialty care physicians, hospitals, and various ancillary providers. Established in 1984, Centene Corporation is headquartered in St. Louis, Missouri.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- CEO
- Sarah London